Insider Transactions in Q2 2021 at Deciphera Pharmaceuticals, Inc. (DCPH)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 03
2021
|
Michael Douglas Taylor Director |
SELL
Open market or private sale
|
Direct |
8,000
-98.13%
|
$368,000
$46.41 P/Share
|
|
May 03
2021
|
Michael Douglas Taylor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+45.69%
|
$16,000
$2.92 P/Share
|
|
Apr 20
2021
|
James Arthur Bristol |
SELL
Open market or private sale
|
Direct |
1,700
-100.0%
|
$76,500
$45.6 P/Share
|
|
Apr 20
2021
|
James Arthur Bristol |
BUY
Exercise of conversion of derivative security
|
Direct |
1,700
+50.0%
|
$5,100
$3.95 P/Share
|
|
Apr 19
2021
|
James Arthur Bristol |
SELL
Open market or private sale
|
Direct |
5,300
-87.74%
|
$243,800
$46.4 P/Share
|
|
Apr 19
2021
|
James Arthur Bristol |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+50.0%
|
$15,900
$3.95 P/Share
|
|
Apr 12
2021
|
James Arthur Bristol |
SELL
Open market or private sale
|
Direct |
14,700
-82.26%
|
$632,100
$43.9 P/Share
|
|
Apr 12
2021
|
James Arthur Bristol |
BUY
Exercise of conversion of derivative security
|
Direct |
14,700
+50.0%
|
$44,100
$3.95 P/Share
|
|
Apr 01
2021
|
Michael Douglas Taylor Director |
SELL
Open market or private sale
|
Direct |
8,000
-70.3%
|
$360,000
$45.74 P/Share
|
|
Apr 01
2021
|
Michael Douglas Taylor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+50.0%
|
$8,000
$1.89 P/Share
|